COCRYSTAL PHARMA, INC. Paid-in-Kind Interest
COCRYSTAL PHARMA, INC. (COCP) reported Paid-in-Kind Interest of $3.24 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2014-03-31
- COCRYSTAL PHARMA, INC. paid-in-kind interest for the quarter ending 2013-12-31 was $1.46M, a 233.37% increase year-over-year.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for the quarter ending 2013-09-30 was $929.80K, a 117.64% increase year-over-year.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for the quarter ending 2013-06-30 was $423.07K, a 55.70% decline year-over-year.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for the quarter ending 2013-03-31 was $422.21K, a 87.43% decline year-over-year.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for fiscal 2013 was $3.24M, a 37.49% decline from fiscal 2012.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for fiscal 2012 was $5.18M, a 583.50% increase from fiscal 2011.
- COCRYSTAL PHARMA, INC. paid-in-kind interest for fiscal 2011 was $758.04K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 3 month as first filed | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 6 month as first filed | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.39M derived: sum of 2 quarters · filed 2014-03-31 | $2.82M derived: sum of 3 quarters · filed 2014-03-31 | $3.24M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | $929.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $1.35M derived: sum of 2 quarters · filed 2013-11-18 | $1.78M 10-Q · filed 2013-11-18 | $2.21M derived: sum of 4 quarters · filed 2014-03-31 | ||
| 2013-06-30 | $423.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $845.29K 10-Q · filed 2013-08-15 | $1.28M derived: sum of 3 quarters · filed 2014-03-31 | $1.71M derived: sum of 4 quarters · filed 2014-03-31 | ||
| 2013-03-31 | $422.21K 10-Q · filed 2013-05-10 | $861.27K derived: sum of 2 quarters · filed 2014-03-31 | $1.29M derived: sum of 3 quarters · filed 2014-03-31 | $2.24M derived: sum of 4 quarters · filed 2014-03-31 | ||
| 2012-12-31 | $439.06K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $866.27K derived: sum of 2 quarters · filed 2014-03-31 | $1.82M derived: sum of 3 quarters · filed 2014-03-31 | $5.18M 10-K · filed 2014-03-31 | ||
| 2012-09-30 | $427.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $1.38M derived: sum of 2 quarters · filed 2013-11-18 | $4.74M 10-Q · filed 2013-11-18 | |||
| 2012-06-30 | $955.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $4.31M 10-Q · filed 2013-08-15 | $11.20M 10-Q/A · filed 2012-09-06 | |||
| 2012-03-31 | $3.36M 10-Q · filed 2013-05-10 | $27.40K 10-Q · filed 2012-05-21 | ||||
| 2011-12-31 | $758.04K 10-K · filed 2013-04-01 | |||||
| 2011-03-31 | $1.85K 10-Q/A · filed 2012-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |